A bioinformatics approach for precision medicine off-label drug drug selection among triple negative breast cancer patients.
Cancer has been extensively characterized on the basis of genomics. The integration of genetic information about cancers with data on how the cancers respond to target based therapy to help to optimum cancer treatment.
Author(s): Cheng, Lijun, Schneider, Bryan P, Li, Lang
DOI: 10.1093/jamia/ocw004